Back

Aminoterminal proB-type natriuretic peptide: a key parameter to optimise therapeutic management of low-flow, low-gradient aortic stenosis

3 September 2019 (16:58 - 17:15)
Organised by:
Congress Presentation Part of: Understanding and treating low gradient aortic stenosis Intervention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Mohamed Salah Annabi

Mcgill, Quebec (Canada)

3 More presentations in this session

Presentation thumbnail
State of the Art in low gradient aortic stenosis diagnosis and management
Professor J. Vanoverschelde (Brussels, BE)
Slides Video
Presentation thumbnail
The role of diastolic function in risk stratification of patients with moderate aortic stenosis
Doctor S. Ito (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Impact of aortic valve replacement on outcomes of patients with low-flow, low-gradient moderate aortic stenosis
Doctor M. Annabi (Quebec, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Understanding and treating low gradient aortic stenosis

The Event

Event poster

ESC Congress 2019

3 September 2019 16:58 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources